Skip to main content
. 2014 Dec 31;113(6):1697–1711. doi: 10.1152/jn.00752.2014

Fig. 6.

Fig. 6.

D1R antagonist SKF93566 blocks SKF81297’s effect on striatonigral IPSCs. A and B: averaged traces shown baseline, bath application of 1 μM SKF81297 and bath application of 1 μM SKF81297 + 2 μM SKF83566 in Pitx3WT mice and Pitx3Null mice, respectively. C: pooled data showing bath application of 2 μM SKF83566 blocked the facilitatory effect of 1 μM SKF81297 on striatonigral IPSCs in Pitx3WT and Pitx3Null mice. *P < 0.05, **P < 0.01, paired t-test. D: pooled data showing 1 μM SKF81297 decreased PPR in Pitx3WT and Pitx3Null mice, which were reversed by bath application of 1 μM SKF81297 + 2 μM SKF83566. *P < 0.05, unpaired t-test. For the PPR during baseline and drug application in Pitx3WT and Pitx3Null mice, P > 0.05, unpaired t-test.